Results 251 to 260 of about 58,087 (312)

Radiopharmaceutical formulation and preliminary clinical dosimetry of [¹⁷⁷Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Zavvar TS, Hörmann AA, Konijnenberg M, Kraihammer M, Mair C, Kronthaler A, Joosten L, Laverman P, Gruber L, di Santo G, Decristoforo C, Virgolini I, von Guggenberg E.   +12 more
europepmc   +1 more source

Outcome of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Progressive Metastatic Neuroendocrine Tumors from a Tertiary Care Center. [PDF]

Indian J Endocrinol Metab
Mathew D, Sunny SS, Benjamin J, John JR, Jebasingh FK, Georgy JT, Singh A, Oommen R.   +7 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy for Sarcoidosis

, 2016
Constantin Lapa, Götz Ulrich Grigoleit, Heribert Hänscheid, Erdwine Klinker, Pius Jung, Ken Herrmann, Andreas Schirbel, Markus Böck, Andreas K. Buck, Theo Pelzer   +9 more
openalex   +1 more source

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up. [PDF]

J Nucl Med
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D, Ranallo N, Azzali I, Di Iorio V, Sarnelli A, Manuela M, Amadori E, Fabbri L, Bartolini D, Tosatto L, Di Meco F, Gurrieri L, Riva N, Calabro L, Matteucci F, Paganelli G, Sansovini M.   +21 more
europepmc   +1 more source

Editorial for the Special Issue "Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design". [PDF]

Curr Issues Mol Biol
Aprile C, Geatti O, Canziani L, Lodola L.   +3 more
europepmc   +1 more source

Lutetium ¹⁷⁷ PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy

, 2017
Louise Emmett, Kathy Willowson, John Violet, Jane Shin, Ashley Blanksby, Jonathan Lee   +5 more
openalex   +1 more source

High-Dose Epidermal Radionuclide Therapy with ¹⁸⁸ Re (Rhenium) Resin in a Patient with Multiple Actinic Keratoses. [PDF]

World J Nucl Med
Mirzaei S, Kunstfeld R.
europepmc   +1 more source

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

, 2017
Keunyoung Kim, Seong‐Jang Kim
openalex   +2 more sources

The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy. [PDF]

J Nucl Med
Yadav S, Lawhn-Heath C, Paciorek A, Lindsay S, Mirro R, Bergsland EK, Hope TA.   +6 more
europepmc   +1 more source

Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy

, 2017
Ryan Clanton, Arnulfo Gonzalez, Sriram Shankar, Gamal Akabani   +3 more
openalex   +2 more sources